证券代码： 301395 证券简称：仁信新材 公告编号： 2025-055 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、新建项目名称：聚苯新材料一体化 12.8 万吨/年低顺聚丁二烯新材料 （LCBR）/溶聚丁苯橡胶（SSBR）项目（项目具体名称以政府部门备案为准） 2、投资金额及资金来源：本项目计划投资总额 150,074.91 万元，拟使用公 司首次公开发行股票超募资金不超过 18,412.57 万元（含理财收益和存款利息收 入），其余由公司自有资金、自筹资金及后续结余的募集资金投入。 3、本次投资不构成关联交易，亦不构成重大资产重组。 4、本次投资事项对公司当期经营业绩不产生重大影响，对未来业绩增长的 影响尚不确定。 惠州仁信新材料股份有限公司（以下简称"公司"）于 2025 年 10 月 27 日 召开第三届董事会第十六次会议，审议通过了《关于使用超募资金投资建设新项 目的议案》，同意公司使用首次公开发行股票超募资金不超过 18,412.57 万元， 投资建设"聚苯新材料一体化 12.8 万吨/年低顺聚丁二烯新材料（LCBR）/溶聚 ...

证券代码： 301395 证券简称：仁信新材 公告编号： 2025-054 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 3、本次对外投资事项尚需提交公司股东会审议。 一、对外投资概述 （一）对外投资的基本情况 惠州仁信新材料股份有限公司（以下简称"公司"或"乙方"）为了扩大 主营业务产能和战略布局，对产业链进行延伸与拓展，进一步巩固和提升公司 的综合竞争力及可持续发展能力，公司拟与惠州大亚湾经济技术开发区管理委 员会石化能源产业局（以下简称"石化能源产业局"或"甲方"）、惠州仁信 科技发展有限公司（公司全资子公司，以下简称"仁信科技"或"丙方"）通 过充分协商，投资建设聚苯新材料一体化项目（下称"本项目"或"项目"）， 拟签订《聚苯新材料一体化项目投资协议》，项目总投资额38亿元，项目分两 期建设，一期投资生产低顺聚丁二烯新材料/溶聚丁苯橡胶、高抗冲聚苯乙烯/ 透明HIPS、聚甲基丙烯酸甲酯/甲基丙烯酸甲酯共聚新材料苯乙烯，二期投资生 产叔丁醇、环氧丙烷、甲基丙烯酸甲酯、丁基橡胶，并由仁信科技根据资金安 排情况，负责项目的投资、建设和运营，其中二期建设待办 ...

仁信新材公告，第三季度营收为5.31亿元，下降0.40%；净利润为787.04万元，下降19.39%。前三季度 营收为16.41亿元，增长4.72%；净利润为3206.53万元，下降2.81%。 ...

Core Viewpoint - The company plans to invest in a new integrated polystyrene materials project with a total investment of 3.8 billion yuan [1] Investment Details - The project will be constructed in two phases, with the first phase focusing on the production of low cis-polybutadiene new materials, styrene-butadiene rubber, high-impact polystyrene, and polymethyl methacrylate [1] - The second phase will involve the production of tert-butanol, propylene oxide, methyl methacrylate, and butyl rubber [1] - The project will cover an area of 264,000 square meters [1] Financial Projections - Upon reaching full production, the project is expected to generate an annual output value/revenue of 7.8 billion yuan and contribute 450 million yuan in annual taxes [1] - Funding for the project will come from the company's own funds, self-raised funds, and funds raised through public offerings [1]

Core Viewpoint - Renxin New Materials (301395.SZ) announced plans to invest in an integrated project for polystyrene new materials in collaboration with the Huizhou Daya Bay Economic and Technological Development Zone [1] Group 1: Project Overview - The total investment for the project is 3.8 billion yuan, which will be constructed in two phases [1] - Phase one will focus on producing low cis polybutadiene new materials, styrene-butadiene rubber, high-impact polystyrene, and polymethyl methacrylate [1] - Phase two will involve the production of tert-butanol, propylene oxide, methyl methacrylate, and butyl rubber [1] Group 2: Financial Projections - Once fully operational, the project is expected to generate an annual output value/revenue of 7.8 billion yuan [1] - The anticipated annual tax contribution from the project is 450 million yuan [1]

证券代码： 301395 证券简称：仁信新材 公告编号： 2025-053 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 惠州仁信新材料股份有限公司（以下简称"公司"）第三届董事会第十六 次会议于2025年10月27日下午在公司会议室以现场结合通讯会议方式召开，会 议通知已于2025年10月23日以书面、通讯方式送达各位董事。公司董事应到9名， 实到9名，其中邱楚开先生、邱洪伟先生、郑志明先生通过通讯方式出席本次会 议。董事长邱汉周先生主持会议，公司高级管理人员列席了本次会议。本次董 事会的召开程序符合《公司法》及《公司章程》的有关规定。 二、董事会会议审议情况 会议采用记名的方式进行表决，经与会的董事表决，审议通过了以下议案： （一）审议通过《关于公司<2025年第三季度报告>的议案》 公司《2025年第三季度报告》的编制程序符合法律、行政法规以及中国证 监会和深圳证券交易所的有关规定，报告内容真实、准确、完整地反映了公司 经营、管理及财务等各方面的实际情况，不存在任何虚假记载、误导性陈述或 者重大遗漏。 具体内容详见同日披露于巨潮 ...

万和证券股份有限公司关于惠州仁信新材料股份有限公司使用超募资金用于新建项目的核查意见 关于惠州仁信新材料股份有限公司 万和证券股份有限公司 使用超募资金用于新建项目的核查意见 万和证券股份有限公司（以下简称"万和证券"或"保荐机构"）作为惠州 仁信新材料股份有限公司（以下简称"仁信新材"或"公司"）首次公开发行股 票并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上市 公司募集资金监管规则》《深圳证券交易所创业板股票上市规则》《深圳证券交易 所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券交易 所上市公司自律监管指引第 13 号——保荐业务》等相关规定，对仁信新材使用 超募资金用于新建项目的事项进行了审慎核查，具体情况如下： 一、本次募集资金的基本情况 2024年11月6日召开第三届董事会第九次会议和第三届监事会第九次会议， 并于 2024 年 11 月 26 日召开 2024 年第四次临时股东大会，分别审议通过《关于 回购公司股份方案的议案》，同意公司以部分超募资金及自筹资金回购公司股份。 截至本公告披露日，回购股份方案已实施完毕，共计使用超募资金 400 万元。具 体 ...

Financial Performance - Q3 2025 revenue was CNY 530,966,283.60, a decrease of 0.40% year-over-year, while year-to-date revenue reached CNY 1,641,225,658.68, an increase of 4.72%[5] - Net profit attributable to shareholders for Q3 2025 was CNY 7,870,365.85, down 19.39% year-over-year, and year-to-date net profit was CNY 32,065,297.54, a decrease of 2.81%[5] - Basic and diluted earnings per share for Q3 2025 were CNY 0.0324, reflecting a decline of 32.64% compared to the same period last year[5] - Total operating revenue for Q3 2025 reached CNY 1,641,225,658.68, an increase of 4.1% compared to CNY 1,567,262,281.01 in the same period last year[18] - Total operating costs amounted to CNY 1,616,347,986.57, up from CNY 1,549,667,061.42, reflecting a year-over-year increase of 4.3%[19] - Net profit for the period was CNY 32,065,297.54, a decrease of 2.8% from CNY 32,991,132.94 in the previous year[19] - The net profit attributable to the parent company's shareholders for the current period is CNY 32,065,297.54, a decrease from CNY 32,991,132.94 in the previous period, representing a decline of approximately 2.8%[20] - Basic and diluted earnings per share for the current period are both CNY 0.1320, down from CNY 0.1626 in the previous period, indicating a decrease of about 18.7%[20] Assets and Liabilities - Total assets as of September 30, 2025, were CNY 2,017,540,822.09, representing a 6.60% increase from the end of the previous year[5] - Current liabilities rose to CNY 427,033,250.32, up from CNY 313,759,369.09, indicating a significant increase of 36.0%[17] - The company's fixed assets increased to CNY 528,240,080.28, compared to CNY 386,001,591.21, representing a growth of 37.0%[17] - The total equity attributable to shareholders decreased to CNY 1,542,440,354.75 from CNY 1,568,923,599.54, a decline of 1.7%[17] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 79,603,529.89, a significant decrease of 1,120.19% year-to-date[5] - Cash inflow from operating activities totaled CNY 1,878,544,394.42, compared to CNY 1,743,319,775.64 in the previous period, reflecting an increase of approximately 7.8%[22] - The net cash flow from operating activities is negative at CNY -79,603,529.89, contrasting with a positive cash flow of CNY 7,802,824.12 in the previous period[22] - Cash inflow from investment activities is CNY 3,569,692,309.02, down from CNY 4,317,496,755.57 in the previous period, representing a decrease of about 17.3%[22] - The net cash flow from investment activities is CNY -874,227,634.13, compared to a positive CNY 287,437,973.65 in the previous period[22] - Cash inflow from financing activities is CNY 176,000,000.00, with a net cash flow of CNY 109,181,165.51, contrasting with a negative cash flow of CNY -147,125,471.36 in the previous period[22] - The ending cash and cash equivalents balance is CNY 162,046,620.84, down from CNY 372,558,918.61 in the previous period, indicating a decrease of approximately 56.5%[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,484[11] - The top three shareholders, Qiu Hanzhou, Qiu Hanyi, and Yang Guoxian, hold 19.23%, 14.11%, and 10.07% of shares respectively[11] - The total number of restricted shares at the end of the period is 115,521,000, with 6,510,000 shares released during the period[13] - The top ten shareholders collectively hold a significant portion of the company's shares, with the largest shareholder holding 46,704,000 shares[11] - The company has a repurchase account holding 3,500,608 shares, accounting for 1.44% of the total share capital[11] - The number of shares held by the top ten unrestricted shareholders includes significant holdings by Zheng Chanyu and Zheng Zhesheng, with 8,736,000 and 8,702,400 shares respectively[11] - The company has not disclosed any changes in the top ten shareholders due to securities lending or borrowing[11] - The company plans to release restricted shares for major shareholders on January 3, 2027[13] Other Financial Metrics - Accounts receivable increased by 35.45% to CNY 72,640,471.76 due to extended credit terms offered to quality customers[9] - Inventory rose by 84.08% to CNY 150,059,367.19, attributed to increased stock for timely order fulfillment[9] - The company reported a significant increase in other non-current assets, up 52,598.27% to CNY 281,517,214.00, mainly due to prepayments for land and equipment[10] - Financial expenses increased by 166.36% to CNY 1,608,668.48, primarily due to the rise in short-term credit borrowings[10] - The company experienced a 54.70% decrease in investment income, totaling CNY 5,749,549.02, due to reduced cash management funds[10] - Research and development expenses for the period were CNY 3,699,375.11, slightly up from CNY 3,602,018.05, reflecting a focus on innovation[19] - The company reported a financial expense of CNY 1,608,668.48, compared to a financial income of CNY -2,424,017.53 in the previous year, indicating a shift in financial performance[19] Accounting and Audit - The company has not undergone an audit for the third quarter financial report[24] - The company plans to implement new accounting standards starting from 2025[24]

第1笔成交价格为8.74元，成交42.80万股，成交金额374.07万元，溢价率为-18.39%，买方营业部为万联 证券股份有限公司广州珠江新城证券营业部，卖方营业部为中国银河证券股份有限公司汕头澄海证券营 业部。 进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为374.07万元。该股近5个交易日累 计下跌3.95%，主力资金合计净流出514.83万元。 10月17日，仁信新材收跌1.92%，收盘价为10.71元，发生1笔大宗交易，合计成交量42.8万股，成交金 额374.07万元。 责任编辑：小浪快报 ...

| 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交金额 (万元) | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | | | | | 2025-10-17 | 301395 | 仁信新材 | 8.74 | 42.80 | | 374.07 万联证券股份有限 | 中国银河证券股份 | | | | | | | | 公司广州珠江新城 | 有限公司汕头澄海 | | | | | | | | 证券营业部 | 证券营业部 | 10月17日，仁信新材大宗交易成交42.8万股，成交额374.07万元，占当日总成交额的15.25%，成交价 8.74元，较市场收盘价10.71元折价18.39%。 ...